The epidemic of prostate cancer and the medical literature: A causal association?

E. Giovannucci, P. Kantoff, D. Spiegelman, K. R. Loughlin, K. I. Wishnow, Christopher Corless, A. McDermott, W. C. Willet, J. A. Talcott

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The diagnosis of prostate cancer has undergone an unprecedented recent increase, while mortality has increased much more slowly. We examined new prostate cancer diagnoses from 1987-1992 in a nationwide prospective cohort study of 51529 men enrolled in the Health Professionals Follow-up Study, a population likely to be medically sophisticated and thus early to adopt medical innovations. The age-adjusted incidence of prostate cancer rose approximately 2 1/2 fold during the study period. Nearly all of the increase occurred among organ-confined tumors, with a smaller increase for regionally-advanced tumors and none for metastatic tumors. Using a Poisson regression model of newly-diagnosed cancers, we found organ-confined cancers rose abruptly by 86% (95% CI: 36-256%; P = 0.0001) and regionally-advanced tumors by 73% (95% CI: 12-267%; P = 0.01) after March, 1991, when a study advocating screening using the prostate specific antigen (PSA) was published in the New England Journal of Medicine. The recent increase in the incidence of prostate cancer is probably due to the increased PSA screening of asymptomatic men, resulting in the diagnosis of large numbers of men with early-stage disease from 1990 onward. Despite ongoing debate over the value of PSA screening, the rate of diagnosis accelerated sharply after the publication of a well-publicized but inconclusive study advocating screening. In a context of growing disease awareness, well-publicized research reports may result in unexpectedly amplified acceptance into medical practice.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalProstate Cancer and Prostatic Diseases
Volume1
Issue number3
StatePublished - 1998
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Prostate-Specific Antigen
Neoplasms
New England
Incidence
Publications
Cohort Studies
Medicine
Prospective Studies
Mortality
Health
Population

Keywords

  • Epidemiology
  • Mass screening
  • Periodicals
  • Prostate-specific antigen
  • Prostatic neoplasms (diagnosis, prevention and control)

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Giovannucci, E., Kantoff, P., Spiegelman, D., Loughlin, K. R., Wishnow, K. I., Corless, C., ... Talcott, J. A. (1998). The epidemic of prostate cancer and the medical literature: A causal association? Prostate Cancer and Prostatic Diseases, 1(3), 148-153.

The epidemic of prostate cancer and the medical literature : A causal association? / Giovannucci, E.; Kantoff, P.; Spiegelman, D.; Loughlin, K. R.; Wishnow, K. I.; Corless, Christopher; McDermott, A.; Willet, W. C.; Talcott, J. A.

In: Prostate Cancer and Prostatic Diseases, Vol. 1, No. 3, 1998, p. 148-153.

Research output: Contribution to journalArticle

Giovannucci, E, Kantoff, P, Spiegelman, D, Loughlin, KR, Wishnow, KI, Corless, C, McDermott, A, Willet, WC & Talcott, JA 1998, 'The epidemic of prostate cancer and the medical literature: A causal association?', Prostate Cancer and Prostatic Diseases, vol. 1, no. 3, pp. 148-153.
Giovannucci E, Kantoff P, Spiegelman D, Loughlin KR, Wishnow KI, Corless C et al. The epidemic of prostate cancer and the medical literature: A causal association? Prostate Cancer and Prostatic Diseases. 1998;1(3):148-153.
Giovannucci, E. ; Kantoff, P. ; Spiegelman, D. ; Loughlin, K. R. ; Wishnow, K. I. ; Corless, Christopher ; McDermott, A. ; Willet, W. C. ; Talcott, J. A. / The epidemic of prostate cancer and the medical literature : A causal association?. In: Prostate Cancer and Prostatic Diseases. 1998 ; Vol. 1, No. 3. pp. 148-153.
@article{e0892aca41fd4d49a56d783219aaf22b,
title = "The epidemic of prostate cancer and the medical literature: A causal association?",
abstract = "The diagnosis of prostate cancer has undergone an unprecedented recent increase, while mortality has increased much more slowly. We examined new prostate cancer diagnoses from 1987-1992 in a nationwide prospective cohort study of 51529 men enrolled in the Health Professionals Follow-up Study, a population likely to be medically sophisticated and thus early to adopt medical innovations. The age-adjusted incidence of prostate cancer rose approximately 2 1/2 fold during the study period. Nearly all of the increase occurred among organ-confined tumors, with a smaller increase for regionally-advanced tumors and none for metastatic tumors. Using a Poisson regression model of newly-diagnosed cancers, we found organ-confined cancers rose abruptly by 86{\%} (95{\%} CI: 36-256{\%}; P = 0.0001) and regionally-advanced tumors by 73{\%} (95{\%} CI: 12-267{\%}; P = 0.01) after March, 1991, when a study advocating screening using the prostate specific antigen (PSA) was published in the New England Journal of Medicine. The recent increase in the incidence of prostate cancer is probably due to the increased PSA screening of asymptomatic men, resulting in the diagnosis of large numbers of men with early-stage disease from 1990 onward. Despite ongoing debate over the value of PSA screening, the rate of diagnosis accelerated sharply after the publication of a well-publicized but inconclusive study advocating screening. In a context of growing disease awareness, well-publicized research reports may result in unexpectedly amplified acceptance into medical practice.",
keywords = "Epidemiology, Mass screening, Periodicals, Prostate-specific antigen, Prostatic neoplasms (diagnosis, prevention and control)",
author = "E. Giovannucci and P. Kantoff and D. Spiegelman and Loughlin, {K. R.} and Wishnow, {K. I.} and Christopher Corless and A. McDermott and Willet, {W. C.} and Talcott, {J. A.}",
year = "1998",
language = "English (US)",
volume = "1",
pages = "148--153",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The epidemic of prostate cancer and the medical literature

T2 - A causal association?

AU - Giovannucci, E.

AU - Kantoff, P.

AU - Spiegelman, D.

AU - Loughlin, K. R.

AU - Wishnow, K. I.

AU - Corless, Christopher

AU - McDermott, A.

AU - Willet, W. C.

AU - Talcott, J. A.

PY - 1998

Y1 - 1998

N2 - The diagnosis of prostate cancer has undergone an unprecedented recent increase, while mortality has increased much more slowly. We examined new prostate cancer diagnoses from 1987-1992 in a nationwide prospective cohort study of 51529 men enrolled in the Health Professionals Follow-up Study, a population likely to be medically sophisticated and thus early to adopt medical innovations. The age-adjusted incidence of prostate cancer rose approximately 2 1/2 fold during the study period. Nearly all of the increase occurred among organ-confined tumors, with a smaller increase for regionally-advanced tumors and none for metastatic tumors. Using a Poisson regression model of newly-diagnosed cancers, we found organ-confined cancers rose abruptly by 86% (95% CI: 36-256%; P = 0.0001) and regionally-advanced tumors by 73% (95% CI: 12-267%; P = 0.01) after March, 1991, when a study advocating screening using the prostate specific antigen (PSA) was published in the New England Journal of Medicine. The recent increase in the incidence of prostate cancer is probably due to the increased PSA screening of asymptomatic men, resulting in the diagnosis of large numbers of men with early-stage disease from 1990 onward. Despite ongoing debate over the value of PSA screening, the rate of diagnosis accelerated sharply after the publication of a well-publicized but inconclusive study advocating screening. In a context of growing disease awareness, well-publicized research reports may result in unexpectedly amplified acceptance into medical practice.

AB - The diagnosis of prostate cancer has undergone an unprecedented recent increase, while mortality has increased much more slowly. We examined new prostate cancer diagnoses from 1987-1992 in a nationwide prospective cohort study of 51529 men enrolled in the Health Professionals Follow-up Study, a population likely to be medically sophisticated and thus early to adopt medical innovations. The age-adjusted incidence of prostate cancer rose approximately 2 1/2 fold during the study period. Nearly all of the increase occurred among organ-confined tumors, with a smaller increase for regionally-advanced tumors and none for metastatic tumors. Using a Poisson regression model of newly-diagnosed cancers, we found organ-confined cancers rose abruptly by 86% (95% CI: 36-256%; P = 0.0001) and regionally-advanced tumors by 73% (95% CI: 12-267%; P = 0.01) after March, 1991, when a study advocating screening using the prostate specific antigen (PSA) was published in the New England Journal of Medicine. The recent increase in the incidence of prostate cancer is probably due to the increased PSA screening of asymptomatic men, resulting in the diagnosis of large numbers of men with early-stage disease from 1990 onward. Despite ongoing debate over the value of PSA screening, the rate of diagnosis accelerated sharply after the publication of a well-publicized but inconclusive study advocating screening. In a context of growing disease awareness, well-publicized research reports may result in unexpectedly amplified acceptance into medical practice.

KW - Epidemiology

KW - Mass screening

KW - Periodicals

KW - Prostate-specific antigen

KW - Prostatic neoplasms (diagnosis, prevention and control)

UR - http://www.scopus.com/inward/record.url?scp=0001582663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001582663&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0001582663

VL - 1

SP - 148

EP - 153

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 3

ER -